Trial Profile
A Prospective, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled, Trial of Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in China
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Oct 2022
Price :
$35
*
At a glance
- Drugs Ulinastatin (Primary)
- Indications Sepsis; Septic shock
- Focus Adverse reactions
- Acronyms ADJUST
- 11 Oct 2022 Status changed from recruiting to completed.
- 14 Jul 2021 Planned End Date changed from 1 Mar 2021 to 20 Sep 2021.
- 21 Sep 2020 Planned End Date changed from 1 Aug 2020 to 1 Mar 2021.